Resolvin D5
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: Yes


Resolvin D5
Description :
Resolvin D5 is a prolytic mediator (SPM) with anti-inflammatory activity derived from oxidized lipids DHA. Resolvin D5 inhibits Th17 cell differentiation and promotes regulatory T cell differentiation, and inhibits CD4+ T cell proliferation. Resolvin D5 attenuates osteoclast differentiation and interferes with osteoclastogenesis. Resolvin D5 also regulates ERK phosphorylation and nuclear translocation of NF-kappaB. Resolvin D5 could be used in rheumatoid arthritis research[1][2].UNSPSC :
12352211Hazard Statement :
H302, H315, H319, H335Target :
ERK; NF-κBType :
Natural ProductsRelated Pathways :
MAPK/ERK Pathway; NF-κB; Stem Cell/WntApplications :
COVID-19-immunoregulationField of Research :
Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/resolvin-d5.htmlConcentration :
277.40 μM * 50 μL in EthanolPurity :
98.3Solubility :
10 mM in DMSOSmiles :
CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\[C@@H](O)C/C=C\CCC(O)=OMolecular Formula :
C22H32O4Molecular Weight :
360.49Precautions :
H302, H315, H319, H335References & Citations :
[1]Yamada H, et al. Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis. Sci Rep. 2021 Aug 27;11 (1) :17312.|[2]Chun HW, et al. Resolvin D5, a Lipid Mediator, Inhibits Production of Interleukin-6 and CCL5 Via the ERK-NF-κB Signaling Pathway in Lipopolysaccharide-Stimulated THP-1 Cells. J Microbiol Biotechnol. 2020 Jan 28;30 (1) :85-92.Shipping Conditions :
Dry IceStorage Conditions :
-80°CScientific Category :
Natural ProductsClinical Information :
No Development ReportedCAS Number :
[578008-43-2]

